IL7 and neoplasm: To assess the potential of C8A8 in enhancing the anti-tumor activity of IL-7-CAR-T cells, we conducted co-culture experiments with various tumor cell lines, including HCC827, H23, and K562, at different effector-to-target (E:T) ratios in the presence of 30 μg/mL C8A8.